sb 203580 has been researched along with sr 144528 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sr 144528) | Trials (sr 144528) | Recent Studies (post-2010) (sr 144528) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 261 | 0 | 76 |
| Protein | Taxonomy | sb 203580 (IC50) | sr 144528 (IC50) |
|---|---|---|---|
| Cannabinoid receptor 1 | Homo sapiens (human) | 0.7943 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 2.009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouchard, JF; Lagneux, C; Lamontagne, D; Lépicier, P | 1 |
1 other study(ies) available for sb 203580 and sr 144528
| Article | Year |
|---|---|
Endocannabinoids protect the rat isolated heart against ischaemia.
Topics: Amides; Animals; Arachidonic Acids; Biomarkers; Blotting, Western; Camphanes; Cannabinoid Receptor Modulators; Endocannabinoids; Ethanolamines; Glycerides; Heart; Imidazoles; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; p38 Mitogen-Activated Protein Kinases; Palmitic Acids; Piperidines; Protein Kinase C; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Rimonabant; Signal Transduction | 2003 |